Ra Capital Management, L.P. Recursion Pharmaceuticals, Inc. Transaction History
Ra Capital Management, L.P.
- $7.17 Billion
- Q3 2024
A detailed history of Ra Capital Management, L.P. transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 15,384,615 shares of RXRX stock, worth $92.8 Million. This represents 1.41% of its overall portfolio holdings.
Number of Shares
15,384,615
Previous 15,384,615
-0.0%
Holding current value
$92.8 Million
Previous $115 Million
12.13%
% of portfolio
1.41%
Previous 1.74%
Shares
1 transactions
Others Institutions Holding RXRX
# of Institutions
286Shares Held
242MCall Options Held
1.35MPut Options Held
2.32M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.8MShares$198 Million2.05% of portfolio
-
Baillie Gifford & CO25.2MShares$152 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.3MShares$146 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$104 Million0.0% of portfolio
-
State Street Corp Boston, MA12.9MShares$77.6 Million0.0% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.09B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...